Medication info
Actorin Tablet 15 mg (Pioglitazone Hydrochloride)

Actorin Tablet 15 mg (Pioglitazone Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Pioglitazone Hydrochloride›16.53mg / 1 tablet
Manufacturer / importer
Nexpam Korea Co., Ltd.
Appearance
White to grayish-white round tablet
Packaging
30 tablets/bottle, 90 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200705479 · Approved 2007.05.14 · Insurance code 662501390

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
This medication is administered orally once daily, with or without food. 1. Monotherapy This medication may be started at 15 mg once daily as monotherapy in patients whose blood glucose is not adequately controlled by diet and exercise. If the initial dose does not provide an adequate effect, the dose may be increased to 30 mg once daily. 2. Combination therapy - When used in combination with a sulfonylurea, the initial dose is 15 mg once daily. - When used in combination with metformin, the initial dose is 15 mg once daily. - When used in combination with insulin, administer 15 mg once daily and adjust the insulin dose according to glycemic control. The maximum recommended dose is 30 mg once daily.
Child dose
Use is not recommended in children under 18 years of age because there is no experience with its use in this population.

Ingredients

Manufacturer
Nexpam Korea Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Blood sugar control issues in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be used alone, but if blood sugar improvement is insufficient despite the use of other oral hypoglycemic agents, it should be co-administered with sulfonylureas, metformin, or insulin. Additionally, it is important for patients with type 2 diabetes to receive nutritional counseling and engage in weight loss and exercise, which not only aids in initial treatment but also helps maintain the effectiveness of drug therapy. Thus, this medication is effectively used for blood sugar control.

How to take

Adult dose

This medication is administered orally once daily, with or without food. 1. Monotherapy This medication may be started at 15 mg once daily as monotherapy in patients whose blood glucose is not adequately controlled by diet and exercise. If the initial dose does not provide an adequate effect, the dose may be increased to 30 mg once daily. 2. Combination therapy - When used in combination with a sulfonylurea, the initial dose is 15 mg once daily. - When used in combination with metformin, the initial dose is 15 mg once daily. - When used in combination with insulin, administer 15 mg once daily and adjust the insulin dose according to glycemic control. The maximum recommended dose is 30 mg once daily.

Child dose

Use is not recommended in children under 18 years of age because there is no experience with its use in this population.

Precautions

This medication is used to treat type 2 diabetes and helps control blood sugar by acting with insulin. This drug may place additional strain on the heart in some patients, potentially causing or worsening heart failure (congestive heart failure), so after starting treatment or increasing the dose, symptoms of heart failure such as weight change, shortness of breath, and swelling should be closely monitored. This medication should not be used in patients with heart failure, and if symptoms of heart failure occur, medical advice should be sought immediately to adjust the treatment. As this drug can cause fluid retention, which increases the risk of heart failure, patients with cardiovascular diseases like heart disease, hypertension, or myocardial infarction should take special caution. Patients with a history of or currently having bladder cancer should not be administered this drug, and if hematuria or urinary disorders occur during treatment, they should inform the physician immediately. Patients with impaired liver function or severe renal impairment should also preferably refrain from using this drug. Women who are pregnant or may become pregnant should not use this medication, and premenopausal women should use appropriate contraception as this drug can stimulate ovulation and raise the risk of pregnancy. During the use of this medication, regular monitoring of blood sugar and liver function tests should be conducted, and if symptoms such as weight gain, swelling, or shortness of breath occur, they should inform a physician immediately. Additionally, the risk of hypoglycemia may increase when this drug is used in conjunction with other diabetes medications or insulin, so when used together, patients should be well-informed about hypoglycemia symptoms and management methods. Elderly patients or those with impaired kidney or liver function should be monitored more closely during administration, and in case of overdose, immediate medical assistance should be sought for appropriate treatment. Finally, the safety and efficacy of this medication have not been confirmed in children, hence it is not used in that age group.

Side effects

  • Congestive heart failure
  • excessive and rapid weight change
  • dyspnea
  • edema
  • fluid retention
  • heart failure
  • visible hematuria
  • urination disorders
  • urgency
  • upper respiratory infection
Show 50 more
  • headache
  • sinusitis
  • myalgia
  • pharyngitis
  • abdominal distension
  • weight gain
  • hypoglycemia
  • urinary tract infection
  • low back pain
  • dizziness
  • diarrhea
  • elevated serum creatine kinase
  • hypertension
  • worsening heart failure
  • vision impairment
  • liver failure
  • fatigue
  • weakness
  • dyspepsia
  • nausea
  • pruritus
  • chest pain
  • tremors
  • chills
  • gastrointestinal disease
  • abdominal pain
  • epigastric discomfort
  • numbness
  • muscle rigidity
  • head discomfort
  • elevated liver enzymes
  • worsening liver disease
  • urticaria
  • eczema
  • arthralgia
  • knee abnormalities
  • weakness in the arms
  • proteinuria
  • increased serum creatinine
  • anxiety
  • insomnia
  • drowsiness
  • simple herpes
  • blurred vision
  • orthostatic hypotension
  • palpitations
  • stroke
  • sexual dysfunction
  • myocardial infarction
  • fracture

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that excludes light and air, avoiding humid places and kept at a temperature between 15 to 30 degrees Celsius. This helps maintain the efficacy of the medication and prevents degradation.

Appearance and packaging

Appearance

White to grayish-white round tablet

Package unit

30 tablets/bottle, 90 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.